Elder Pharmaceuticals, a Rs.1,325 crore plus Mumbai based pharma company, has posted net profit of Rs.18.67 crore during the third quarter ended December 2012 as compared to Rs.18.29 in the corresponding period of last year. Its net sales increased by 9 per cent to Rs.374 crore from Rs.343 crore. EBDITA improved by 9.7 per cent to Rs.62.90 crore from Rs.57.35 crore. Its interest burden went up by 39.2 per cent to Rs.30.97 crore from Rs.22.25 crore. EPS worked out to Rs.9.09 as against Rs.8.91 in the last period.

For the nine months period ended December 2012, Elder's net sales increased by 16.2 per cent to Rs.1,132 crore from Rs.974 crore in the similar period of last year. Its net profit increased by 4.5 per cent to Rs.60.31 crore from Rs.57.75 crore.

With almost stagnant profit, Elder scrip declined by over Rs.12 on BSE in the afternoon session to Rs.349.30 from its previous day's closing of Rs.361.65.